Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.32
-0.07 (-0.83%)
At close: Jul 11, 2025, 4:00 PM
8.22
-0.10 (-1.20%)
After-hours: Jul 11, 2025, 6:32 PM EDT
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $2.61 billion as of July 11, 2025. Its market cap has increased by 30.14% in one year.
Market Cap
2.61B
Enterprise Value
5.13B
1-Year Change
30.14%
Ranking
Category
Stock Price
$8.32
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $2.61B, a decrease of -54.68%. That is a compound annual growth rate of -10.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 2.61B | 6.39% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |